FEAR & GREED | Business NewsFEAR & GREED | Business News

Interview: Why this biotech chose the ASX over the NASDAQ

View descriptionShare

Imagion Biosystems is a biotech company aiming to make a difference to the lives of cancer patients, with groundbreaking imaging techniques being trialled in Australian hospitals.

CEO Bob Proulx joins Sean Aylmer from San Diego to talk about Imagion's work, and why they chose to list on the ASX.

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. FEAR & GREED | Business News

    3,417 clip(s)

FEAR & GREED | Business News

Daily business news for people who make their own decisions, with business journalist Sean Aylmer an 
Social links
Follow podcast
Recent clips
Browse 3,416 clip(s)